Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases

Neuropsychopharmacology- United Kingdom

doi 10.1038/npp.2013.111

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Evolution of Presence of Predominant Negative Symptoms in Patients With Schizophrenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2014English

Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients With Schizophrenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Lisdexamfetamine Dimesylate for Preschool Children With Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2020English

Social Interaction and Social Withdrawal in Rodents as Readouts for Investigating the Negative Symptoms of Schizophrenia

European Neuropsychopharmacology
PsychiatryMental HealthNeurologyBiological PsychiatryPharmacology
2014English

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Lisdexamfetamine Dimesylate Augmentation for Major Depressive Disorder in Adults With Inadequate Response to Antidepressant Therapy

Journal of Psychopharmacology
MedicinePsychiatryMental HealthPharmacology
2017English

Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

CNS Spectrums
PsychiatryMental HealthNeurology
2009English

Efficacy of Lisdexamfetamine Dimesylate Throughout the Day in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Randomized, Controlled Trial

European Child and Adolescent Psychiatry
DevelopmentalMental HealthPediatricsEducational PsychologyPhilosophyPerinatologyPsychiatryMedicineChild Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy